Research Article
Volume 8 Issue 12 - 2020
The Use and Abuse of Supplements among Thalassemia Major Patients, Cross Sectional Study from Saudi Arabia
Mohamad Qari1*, Alanoud Musaad Alzahrani2, Kulthoum Basheer Fallatah3, Jumana Zuhair Alzuhayri4, Douha Faisal Alnemari5, Sara Saad Waheeb6 and Ghadir Saeed Mahi6
1Professor of Hematology, Faculty of Medicine, King Abdulaziz University, University in Jeddah, Saudi Arabia
2Medical Intern at Batterjee Medical College, Medical school in Jeddah, Saudi Arabia
3Bachelor Degree for Department of Sciences, Division of Medical Physics at King Abdelaziz University, Student at ibn Sina National College for Medical Studies, College in Jeddah, Saudi Arabia
4Bachelor of Science in Biochemistry, King Abdulaziz University, College in Jeddah, Saudi Arabia
5Pharmacist at International Medical Center, College in Jeddah, Saudi Arabia
6Student at Ibn Sina National College for Medical Studies, College in Jeddah, Saudi Arabia
*Corresponding Author: Mohamad Qari, Professor of Hematology Faculty of Medicine, King Abdulaziz University, University in Jeddah, Saudi Arabia.
Received: July 29, 2020; Published: November 25, 2020


Background: Thalassemia is a congenital hemolytic disease. Beta- thalassemia major is a disease that requires regular blood transfusion and diverse supportive measures. we evaluated the effect and types of supplements use among B-Thalassemia major patients.

Methods: This study was conducted among thalassemia major patients in King Abdul Aziz University Hospital in Jeddah between February 2019 - March 2019 after receiving IRB approval and patient consent. Data were collected by using a questionnaire. Sample size 63 both genders. The data were analyzed using SPSS version 25.

Results: 283 individuals were accepted to participate in this study as they were diagnosed with beta thalassemia. Only 63 questionnaires were completed. The median age of the patients was 21 years (range 67 years). The majority of our sample were adults at 47%. The general health status in 58.7% was reported to be excellent. The prevalence of supplement use was (95.2%), folic acid being the most commonly used supplement (88.88%), vitamin D and calcium came in second (74.6%). Physicians held the accountability as the highest rank of information source for the patients (84.1%). The increase in general health was the main reason for supplement use (88.88%).

Conclusion: The majority of patients were found to have used folic acid, vitamin D and calcium, respectively to improve general health and well-being. Based on that we recommend to raise awareness and educate the physicians about the importance of the least used supplements in our study such as zinc, vitamin C and vitamin E.

Keywords: Thalassemia; Folic Acid; Vitamin D; Calcium


  1. Taher AT., et al. “Thalassaemia”. Lancet10116 (2018): 155-167.
  2. Pinto VM., et al. “Management of the aging beta-thalassemia transfusion-dependent population - The Italian experience”. Blood Reviews 38 (2019): 100594.
  3. Viprakasit V and Ekwattanakit S. “Clinical Classification, Screening and Diagnosis for Thalassemia”. Hematology/Oncology Clinics of North America 2 (2018): 193-211.
  4. Ferrier DRA. “Lippincott's illustrated reviews: biochemistry”. Sixth international edition.
  5. Baghersalimi A., et al. “Assessment of Serum Folic Acid and Homocysteine in Thalassemia Major Patients Before and After Folic Acid Supplement Cessation”. Pediatric Hematology and Oncology 7 (2018): 504-507.
  6. Khezri HD. “Is Vitamin C Supplementation in Patients with β-Thalassemia Major Beneficial or Detrimental? Zeydi, A. E., Edition (2016): 293-294.
  7. Ozturk Z., et al. “Minerals in thalassemia major patients: An overview”. Journal of Trace Elements in Medicine and Biology 41 (2017): 1-9.
  8. Cunningham E. “Is There a Special Diet for Thalassemia?” Journal of the Academy of Nutrition and Dietetics 8 (2016): 1360.
  9. Fung EB., et al. “Zinc supplementation improves bone density in patients with thalassemia: a double-blind, randomized, placebo-controlled trial”. The American Journal of Clinical Nutrition 4 (2013): 960-971.
  10. Elalfy MS., et al. “Role of vitamin C as an adjuvant therapy to different iron chelators in young β-thalassemia major patients: efficacy and safety in relation to tissue iron overload”. European Journal of Haematology 3 (2016): 318-326.
  11. Qwader MR. “Evaluation of osteopathy and vitamin D status in patients with beta-thalassemia major”. Sherief, l. m., Edition. Zagazig University Medical Journal (2019).
  12. Giusti A., et al. “Management of beta-thalassemia-associated osteoporosis”. Annals of the New York Academy of Sciences 1 (2016): 73-81.
  13. Trangsuwan D. “Effects of Vitamin E on Transfusion Requirements in Transfusion Dependent Beta-Thalassemia Patients”. Wongchanchailert, M., Edition (2018).
  14. Bordbar M., et al. “Complementary and alternative medicine use in thalassemia patients in Shiraz, southern Iran: A cross-sectional study”. Journal of Traditional and Complementary Medicine 1 (2018): 141-146.
  15. Tonekaboni SH., et al. “Use of complementary and alternative medicine for epileptic children in tehran: a cross-sectional study (2009-2011)”. Iranian Journal of Child Neurology 1 (2014): 26-31.
  16. Dede AD., et al. “Thalassemia-associated osteoporosis: a systematic review on treatment and brief overview of the disease”. Osteoporosis International 12 (2016): 3409-3425.
  17. De Sanctis V., et al. “Osteoporosis in thalassemia major: an update and the I-CET 2013 recommendations for surveillance and treatment”. Pediatric Endocrinology Reviews 2 (2013): 167-180.
  18. Singh MM., et al. “Determining Nt-proBNP Levels with Diastolic Dysfunction in Thalassemia Major Patients”. Journal of Trace Elements in Medicine and Biology 4 (2017): 222-226.
  19. Nidumuru S., et al. “Evaluating the Role of Zinc in Beta Thalassemia Major: A Prospective Case-Control Study from a Tertiary Care Teaching Hospital in India”. Cureus7 (2017): e1495.
Citation: Mohamad Qari., et al. “The Use and Abuse of Supplements among Thalassemia Major Patients, Cross Sectional Study from Saudi Arabia”. EC Pharmacology and Toxicology 8.12 (2020): 14-21.

PubMed Indexed Article

EC Pharmacology and Toxicology
LC-UV-MS and MS/MS Characterize Glutathione Reactivity with Different Isomers (2,2' and 2,4' vs. 4,4') of Methylene Diphenyl-Diisocyanate.

PMID: 31143884 [PubMed]

PMCID: PMC6536005

EC Pharmacology and Toxicology
Alzheimer's Pathogenesis, Metal-Mediated Redox Stress, and Potential Nanotheranostics.

PMID: 31565701 [PubMed]

PMCID: PMC6764777

EC Neurology
Differences in Rate of Cognitive Decline and Caregiver Burden between Alzheimer's Disease and Vascular Dementia: a Retrospective Study.

PMID: 27747317 [PubMed]

PMCID: PMC5065347

EC Pharmacology and Toxicology
Will Blockchain Technology Transform Healthcare and Biomedical Sciences?

PMID: 31460519 [PubMed]

PMCID: PMC6711478

EC Pharmacology and Toxicology
Is it a Prime Time for AI-powered Virtual Drug Screening?

PMID: 30215059 [PubMed]

PMCID: PMC6133253

EC Psychology and Psychiatry
Analysis of Evidence for the Combination of Pro-dopamine Regulator (KB220PAM) and Naltrexone to Prevent Opioid Use Disorder Relapse.

PMID: 30417173 [PubMed]

PMCID: PMC6226033

EC Anaesthesia
Arrest Under Anesthesia - What was the Culprit? A Case Report.

PMID: 30264037 [PubMed]

PMCID: PMC6155992

EC Orthopaedics
Distraction Implantation. A New Technique in Total Joint Arthroplasty and Direct Skeletal Attachment.

PMID: 30198026 [PubMed]

PMCID: PMC6124505

EC Pulmonology and Respiratory Medicine
Prevalence and factors associated with self-reported chronic obstructive pulmonary disease among adults aged 40-79: the National Health and Nutrition Examination Survey (NHANES) 2007-2012.

PMID: 30294723 [PubMed]

PMCID: PMC6169793

EC Dental Science
Important Dental Fiber-Reinforced Composite Molding Compound Breakthroughs

PMID: 29285526 [PubMed]

PMCID: PMC5743211

EC Microbiology
Prevalence of Intestinal Parasites Among HIV Infected and HIV Uninfected Patients Treated at the 1o De Maio Health Centre in Maputo, Mozambique

PMID: 29911204 [PubMed]

PMCID: PMC5999047

EC Microbiology
Macrophages and the Viral Dissemination Super Highway

PMID: 26949751 [PubMed]

PMCID: PMC4774560

EC Microbiology
The Microbiome, Antibiotics, and Health of the Pediatric Population.

PMID: 27390782 [PubMed]

PMCID: PMC4933318

EC Microbiology
Reactive Oxygen Species in HIV Infection

PMID: 28580453 [PubMed]

PMCID: PMC5450819

EC Microbiology
A Review of the CD4 T Cell Contribution to Lung Infection, Inflammation and Repair with a Focus on Wheeze and Asthma in the Pediatric Population

PMID: 26280024 [PubMed]

PMCID: PMC4533840

EC Neurology
Identifying Key Symptoms Differentiating Myalgic Encephalomyelitis and Chronic Fatigue Syndrome from Multiple Sclerosis

PMID: 28066845 [PubMed]

PMCID: PMC5214344

EC Pharmacology and Toxicology
Paradigm Shift is the Normal State of Pharmacology

PMID: 28936490 [PubMed]

PMCID: PMC5604476

EC Neurology
Examining those Meeting IOM Criteria Versus IOM Plus Fibromyalgia

PMID: 28713879 [PubMed]

PMCID: PMC5510658

EC Neurology
Unilateral Frontosphenoid Craniosynostosis: Case Report and a Review of the Literature

PMID: 28133641 [PubMed]

PMCID: PMC5267489

EC Ophthalmology
OCT-Angiography for Non-Invasive Monitoring of Neuronal and Vascular Structure in Mouse Retina: Implication for Characterization of Retinal Neurovascular Coupling

PMID: 29333536 [PubMed]

PMCID: PMC5766278

EC Neurology
Longer Duration of Downslope Treadmill Walking Induces Depression of H-Reflexes Measured during Standing and Walking.

PMID: 31032493 [PubMed]

PMCID: PMC6483108

EC Microbiology
Onchocerciasis in Mozambique: An Unknown Condition for Health Professionals.

PMID: 30957099 [PubMed]

PMCID: PMC6448571

EC Nutrition
Food Insecurity among Households with and without Podoconiosis in East and West Gojjam, Ethiopia.

PMID: 30101228 [PubMed]

PMCID: PMC6086333

EC Ophthalmology
REVIEW. +2 to +3 D. Reading Glasses to Prevent Myopia.

PMID: 31080964 [PubMed]

PMCID: PMC6508883

EC Gynaecology
Biomechanical Mapping of the Female Pelvic Floor: Uterine Prolapse Versus Normal Conditions.

PMID: 31093608 [PubMed]

PMCID: PMC6513001

EC Dental Science
Fiber-Reinforced Composites: A Breakthrough in Practical Clinical Applications with Advanced Wear Resistance for Dental Materials.

PMID: 31552397 [PubMed]

PMCID: PMC6758937

EC Microbiology
Neurocysticercosis in Child Bearing Women: An Overlooked Condition in Mozambique and a Potentially Missed Diagnosis in Women Presenting with Eclampsia.

PMID: 31681909 [PubMed]

PMCID: PMC6824723

EC Microbiology
Molecular Detection of Leptospira spp. in Rodents Trapped in the Mozambique Island City, Nampula Province, Mozambique.

PMID: 31681910 [PubMed]

PMCID: PMC6824726

EC Neurology
Endoplasmic Reticulum-Mitochondrial Cross-Talk in Neurodegenerative and Eye Diseases.

PMID: 31528859 [PubMed]

PMCID: PMC6746603

EC Psychology and Psychiatry
Can Chronic Consumption of Caffeine by Increasing D2/D3 Receptors Offer Benefit to Carriers of the DRD2 A1 Allele in Cocaine Abuse?

PMID: 31276119 [PubMed]

PMCID: PMC6604646

EC Anaesthesia
Real Time Locating Systems and sustainability of Perioperative Efficiency of Anesthesiologists.

PMID: 31406965 [PubMed]

PMCID: PMC6690616

EC Pharmacology and Toxicology
A Pilot STEM Curriculum Designed to Teach High School Students Concepts in Biochemical Engineering and Pharmacology.

PMID: 31517314 [PubMed]

PMCID: PMC6741290

EC Pharmacology and Toxicology
Toxic Mechanisms Underlying Motor Activity Changes Induced by a Mixture of Lead, Arsenic and Manganese.

PMID: 31633124 [PubMed]

PMCID: PMC6800226

EC Neurology
Research Volunteers' Attitudes Toward Chronic Fatigue Syndrome and Myalgic Encephalomyelitis.

PMID: 29662969 [PubMed]

PMCID: PMC5898812

EC Pharmacology and Toxicology
Hyperbaric Oxygen Therapy for Alzheimer's Disease.

PMID: 30215058 [PubMed]

PMCID: PMC6133268

News and Events

April Issue Release

We always feel pleasure to share our updates with you all. Here, notifying you that we have successfully released the April issue of respective journals and the latest articles can be viewed on the current issue pages.

Submission Deadline for upcoming Issue

Ecronicon delightfully welcomes all the authors around the globe for effective collaboration with an article submission for the upcoming issue of respective journals. Submissions are accepted on/before May 04, 2021.

Certificate of Publication

Ecronicon honors with a "Publication Certificate" to the corresponding author by including the names of co-authors as a token of appreciation for publishing the work with our respective journals.

Best Article of the Issue

Editors of respective journals will always be very much interested in electing one Best Article after each issue release. The authors of the selected article will be honored with a "Best Article of the Issue" certificate.

Certifying for Review

Ecronicon certifies the Editors for their first review done towards the assigned article of the respective journals.

Latest Articles

The latest articles will be updated immediately on the articles in press page of the respective journals.

Immediate Assistance

The prime motto of this team is to clarify all the queries without any delay or hesitation to avoid the inconvenience. For immediate assistance on your queries please don't hesitate to drop an email to